← FDA Drug Approvals (Drugs@FDA)

OSENVELT

BLA · Biologics License Application · Sponsor: CELLTRION INC · Approved 2025-02-28

Drug application

FDA Application #
BLA761404
Application type
Biologics License Application
Brand name
OSENVELT
Generic name
DENOSUMAB-BMWO
Active ingredients
DENOSUMAB-BMWO
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
CELLTRION INC
Manufacturer
CELLTRION USA, Inc.
First approval
2025-02-28

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown